메뉴 건너뛰기




Volumn 44, Issue 4, 1996, Pages 364-371

Statistical designs for phase II trials;Plans experimentaux pour l'inclusion de patients dan les essais de phase II

Author keywords

clinical trials; phase II; statistical test

Indexed keywords

ARTICLE; DRUG EFFICACY; HUMAN; PHASE 2 CLINICAL TRIAL; STATISTICAL ANALYSIS; DECISION MAKING; EPIDEMIOLOGY; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PATIENT SELECTION; PROBABILITY; STATISTICAL MODEL; TREATMENT FAILURE;

EID: 0030207638     PISSN: 03987620     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (2)

References (4)
  • 1
    • 50549174560 scopus 로고
    • The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapy agent
    • Gehan EA. The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapy agent. J Chronic Dis 1961 ; 13 : 346-53.
    • (1961) J Chronic Dis , vol.13 , pp. 346-353
    • Gehan, E.A.1
  • 2
    • 0020108590 scopus 로고
    • One sample multiple testing procedure for phase II clinical trials
    • Fleming TR. One sample multiple testing procedure for phase II clinical trials. Biometrics 1982 ; 38 : 143-51.
    • (1982) Biometrics , vol.38 , pp. 143-151
    • Fleming, T.R.1
  • 3
    • 0024536437 scopus 로고
    • Optimal two-stage designs for phase II clinical trials
    • Simon R. Optimal two-stage designs for phase II clinical trials. Controlled Clin Trials 1989 ; 10 : 1-10.
    • (1989) Controlled Clin Trials , vol.10 , pp. 1-10
    • Simon, R.1
  • 4
    • 0028069010 scopus 로고
    • An optimal three-stage design for phase II clinical trials
    • Ensign LG, Gehan EA, Kamen DS, Thall P. An optimal three-stage design for phase II clinical trials. Stat Med 1994 ; 13 : 1727-36.
    • (1994) Stat Med , vol.13 , pp. 1727-1736
    • Ensign, L.G.1    Gehan, E.A.2    Kamen, D.S.3    Thall, P.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.